PETMED EXPRESS INC

For the period ended Mar 31, 2026. Filed Jun 2, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Jun 2, 2026

PETS$1.21-3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of and

(in thousands, except for share and per share amounts)

	March 31,2026	March 31,2025
ASSETS
Current assets:
Cash and cash equivalents	$21,412	$54,720
Accounts receivable, less allowance for credit losses of $25 and $91, respectively	1,908	2,317
Inventories, net	13,608	16,205
Prepaid expenses and other current assets	6,378	5,330
Prepaid income taxes	258	299
Total current assets	43,564	78,871
Noncurrent assets:
Property and equipment, net	26,326	28,859
Intangible and other assets, net	10,789	13,346
Goodwill	—	26,658
Operating lease right-of-use assets, net	512	966
Total noncurrent assets	37,627	69,829
Total assets	$81,191	$148,700
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable	$20,906	$23,564
Sales tax payable	22,261	24,867
Accrued expenses and other current liabilities	7,665	11,711
Current operating lease liabilities	493	461
Deferred revenue	689	2,085
Income taxes payable	20	80
Total current liabilities	52,034	62,768
Deferred tax liabilities, net	175	263
Long-term operating lease liabilities	42	535
Total liabilities	$52,251	$63,566
Commitments and contingencies (Note 14)
Shareholders' equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized:
Convertible Preferred stock, $0.001 par value, with a liquidation preference of $4 per share, 250,000 shares authorized; 2,500 and 2,500 convertible shares issued and outstanding, respectively	9	9
Series A Junior Participating Preferred Stock, $0.001 par value, 100,000 shares authorized; no shares issued or outstanding	—	—
Common stock, $.001 par value, 40,000,000 shares authorized; 21,385,638 and 20,656,822 shares issued and outstanding, respectively	21	21
Additional paid-in capital	19,647	18,560
Retained earnings	9,263	66,544
Total shareholders' equity	28,940	85,134
Total liabilities and shareholders' equity	$81,191	$148,700

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.